• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Competitive fitness and homologous recombination of SARS-CoV-2 variants of concern

tetano

Editor, Senior Moderator
J Med Virol


. 2023 Dec;95(12):e29278.
doi: 10.1002/jmv.29278. Competitive fitness and homologous recombination of SARS-CoV-2 variants of concern

Qi Chen[SUP] 1 [/SUP], Si Qin[SUP] 1 [/SUP], Hang-Yu Zhou[SUP] 2 [/SUP], Yong-Qiang Deng[SUP] 1 [/SUP], Pan-Deng Shi[SUP] 1 [/SUP], Hui Zhao[SUP] 1 [/SUP], Xiao-Feng Li[SUP] 1 [/SUP], Xing-Yao Huang[SUP] 1 [/SUP], Ya-Rong Wu[SUP] 1 [/SUP], Yan Guo[SUP] 1 [/SUP], Guang-Qian Pei[SUP] 1 [/SUP], Yun-Fei Wang[SUP] 1 [/SUP], Si-Qi Sun[SUP] 1 [/SUP], Zong-Min Du[SUP] 1 [/SUP], Yu-Jun Cui[SUP] 1 [/SUP], Hang Fan[SUP] 1 [/SUP], Cheng-Feng Qin[SUP] 1 3 [/SUP]



Affiliations
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge and cocirculate in humans and wild animals. The factors driving the emergence and replacement of novel variants and recombinants remain incompletely understood. Herein, we comprehensively characterized the competitive fitness of SARS-CoV-2 wild type (WT) and three variants of concern (VOCs), Alpha, Beta and Delta, by coinfection and serial passaging assays in different susceptible cells. Deep sequencing analyses revealed cell-specific competitive fitness: the Beta variant showed enhanced replication fitness during serial passage in Caco-2 cells, whereas the WT and Alpha variant showed elevated fitness in Vero E6 cells. Interestingly, a high level of neutralizing antibody sped up competition and completely reshaped the fitness advantages of different variants. More importantly, single clone purification identified a significant proportion of homologous recombinants that emerged during the passage history, and immune pressure reduced the frequency of recombination. Interestingly, a recombination hot region located between nucleotide sites 22,995 and 28,866 of the viral genomes could be identified in most of the detected recombinants. Our study not only profiled the variable competitive fitness of SARS-CoV-2 under different conditions, but also provided direct experimental evidence of homologous recombination between SARS-CoV-2 viruses, as well as a model for investigating SARS-CoV-2 recombination.

Keywords: SARS-CoV-2; competitive fitness; homologous recombination.

 
Back
Top Bottom